The following Structured Product Label (SPL) was submitted to the FDA by Bispit Canada Ltd. for the product Breast Nodule (NDC 85631-010). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, otc - keep out of reach of children, otc - purpose, indications & usage, dosage & administration, warnings, inactive ingredient, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
CURCUMA AROMATICA ROOT
BLACK PEPPER
TARAXACUM OFFICINALE
ROSA RUGOSA FLOWER
CITRUS MEDICA VAR. SARCODACTYLIS WHOLE
TANGERINE PEEL
CRATAEGUS RIVULARIS WHOLE
PRUNUS PERSICA SEED
ANGELICA SINENSIS ROOT
1. Do not use with Veratrum nigrum.2. Please keep the drug properly andkeep away from the children.
Promoting
Blood Circulation in The Breast
Alleviating
Breast Nodules
Dosage:For prevention: once per day,2 tablets per dosing.Patient with nodule: twice per day.2 tablets per dosing (doubled forsevere patient).
For prevention: once per day,2 tablets per dosing.Patient with nodule: twice per day,2 tablets per dosing (doubled forsevere patient).
Unsuitable For:*Children, pregnant women, and nursingmothers.
Women with heavy menstrual volumeshall pause or adjust the dosage, andindividual with a tendency to bleed(such as those taking anticoagulantslike Aspirin or Warfarin), or thosepreparing for a surgery.
Magnesium stearateć Sorbitol.
Labeling (85631 010 01)
* Please review the disclaimer below.
